Psilopatis, I.; Damaskos, C.; Garmpi, A.; Sarantis, P.; Koustas, E.; Antoniou, E.A.; Dimitroulis, D.; Kouraklis, G.; Karamouzis, M.V.; Vrettou, K.;
et al. FDA-Approved Monoclonal Antibodies for Unresectable Hepatocellular Carcinoma: What Do We Know So Far? Int. J. Mol. Sci. 2023, 24, 2685.
https://doi.org/10.3390/ijms24032685
AMA Style
Psilopatis I, Damaskos C, Garmpi A, Sarantis P, Koustas E, Antoniou EA, Dimitroulis D, Kouraklis G, Karamouzis MV, Vrettou K,
et al. FDA-Approved Monoclonal Antibodies for Unresectable Hepatocellular Carcinoma: What Do We Know So Far? International Journal of Molecular Sciences. 2023; 24(3):2685.
https://doi.org/10.3390/ijms24032685
Chicago/Turabian Style
Psilopatis, Iason, Christos Damaskos, Anna Garmpi, Panagiotis Sarantis, Evangelos Koustas, Efstathios A. Antoniou, Dimitrios Dimitroulis, Gregory Kouraklis, Michail V. Karamouzis, Kleio Vrettou,
and et al. 2023. "FDA-Approved Monoclonal Antibodies for Unresectable Hepatocellular Carcinoma: What Do We Know So Far?" International Journal of Molecular Sciences 24, no. 3: 2685.
https://doi.org/10.3390/ijms24032685
APA Style
Psilopatis, I., Damaskos, C., Garmpi, A., Sarantis, P., Koustas, E., Antoniou, E. A., Dimitroulis, D., Kouraklis, G., Karamouzis, M. V., Vrettou, K., Marinos, G., Kontzoglou, K., & Garmpis, N.
(2023). FDA-Approved Monoclonal Antibodies for Unresectable Hepatocellular Carcinoma: What Do We Know So Far? International Journal of Molecular Sciences, 24(3), 2685.
https://doi.org/10.3390/ijms24032685
